SS Innovations International (SSII)
Builds surgical robotics around the SSi Mantra platform.
$3.12
vs last close−0.18 (−5.45%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 7 | 4 | 4 | 6 | 5 | 10 | 13 | 15 | 11 | 14 |
| Cost of revenue | 1 | 2 | 4 | 4 | 2 | 3 | 4 | 4 | 7 | 8 | 6 | 7 |
| Gross profit | 0 | 0 | 3 | 1 | 2 | 3 | 1 | 6 | 6 | 6 | 5 | 7 |
| 2 | 15 | 6 | 4 | 6 | 11 | 7 | 6 | 8 | 7 | 9 | 9 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 2 |
| 2 | 15 | 5 | 3 | 5 | 10 | 6 | 5 | 7 | 5 | 8 | 4 | |
| General & administrative | 2 | 15 | 5 | 0 | 5 | 10 | 6 | 5 | 7 | 5 | 0 | 4 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | −1 | 0 | 0 | 0 | 0 | 0 | 3 |
| Operating income | −2 | −15 | −3 | −3 | −3 | −8 | −6 | 0 | −2 | −1 | −4 | −2 |
| 0 | −1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 0 | 0 | 0 | −1 | 0 |
| Income before tax | −2 | −16 | −3 | −3 | −3 | −7 | −6 | 0 | −2 | −1 | −3 | −2 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 1 |
| Net income from continuing operations | −2 | −16 | −3 | −3 | −3 | −7 | −6 | 0 | −4 | −2 | −4 | −3 |
| Net income | −2 | −16 | −3 | −3 | −3 | −7 | −6 | 0 | −4 | −2 | −4 | −3 |
| EPS, basic | −$0.01 | −$0.09 | −$0.02 | −$0.02 | −$0.02 | −$0.04 | −$0.03 | −$0.00 | −$0.02 | −$0.01 | −$0.02 | −$0.01 |
| EPS, diluted | −$0.01 | −$0.09 | −$0.02 | −$0.02 | −$0.02 | −$0.04 | −$0.03 | −$0.00 | −$0.02 | −$0.01 | −$0.02 | −$0.01 |
| Weighted average shares, basic | 170 | 171 | 171 | 171 | 171 | 171 | 179 | 194 | 194 | 190 | 196 | 200 |
| Weighted average shares, diluted | 170 | 171 | 171 | 171 | 182 | 182 | 189 | 203 | 203 | 199 | 205 | 209 |
| EBITDA | −2 | −16 | −3 | −2 | −3 | −7 | −5 | 1 | −1 | 0 | −3 | −2 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −2 | −16 | −3 | −3 | −3 | −7 | −5 | 0 | −2 | 0 | −3 | −2 |
